OCT 25, 2020 10:05 PM PDT

Over 4 in 10 People With MS Have Used Cannabis in the Last Year

WRITTEN BY: Angela Dowden

University of Michigan researchers have found that Americans with Multiple sclerosis (MS) are twice as likely as the general US population to report using use cannabis or cannabinoid-based therapies.

According to the National Organization for the Reform of Marijuana Laws (NORML), 22.6 percent of US adults reported using marijuana within the last year, whereas the Michigan researchers found that 42 percent of people MS did so.

The study, “Cannabinoid use among Americans with MS: Current trends and gaps in knowledge,” was published in Multiple Sclerosis Journal – Experimental, Translational and Clinical. It set out to assess the prevalence and self-reported effectiveness of cannabinoid use among MS patients in the US, as well as the role played by healthcare providers in guiding patients on use of the drug.

Of the 1,217 survey respondents, a total of 1,027 answered the question about cannabis use in the past year. Among these, 427 (42 percent) endorsed cannabis use, of whom 386 (90 percent of this subgroup) said they used cannabis either strictly for medical purposes, or for both  medical and recreational purposes.

A striking finding was that only 1 percent of users said they had received assistance from their healthcare provider regarding selection of cannabinoid formulations.

Less that than one in five discussed use of cannabinoids with their healthcare provider at all.

The researchers found that MS patients who were affected more severely by pain, anxiety, depression, pain and sleep disturbances were those more likely to use cannabis products than those les affected.

On a scale of 0 to 10, where 0=no relief and 10=extreme relief, MS patients rated relief between 6.1 and 8 depending on symptom. Sleep problems and tremors were symptoms rated as most improved with cannabis.

Interestingly, where users expressed a preference for formulations with higher or lower concentrations of cannabidiol/tetrahydrocannibinol (CBD/THC) a significantly higher proportion of patients who used and liked THC-predominant formulations, experienced improvement in ability to fall asleep, and pain interfering with sleep (THC is the psychoactive component in cannabis).

The researchers wrote: ”Many Americans with MS use cannabinoids, and CBD-predominant products in particular, to self-manage a wide range of symptoms. These findings highlight crucial gaps between community use and clinical care, and illustrate an immediate need for prospective, mechanistic studies focused on the effects of cannabinoids for chronic MS symptoms, as well as interactions between MS symptoms.”

 

Sources: High Times, Multiple Sclerosis News Today

 

 

 

 

About the Author
  • I'm a journalist and author with many year's experience of writing for both a consumer and professional audience, mostly on nutrition, health and medical prescribing. My background is food science and I'm a registered nutritionist.
You May Also Like
SEP 28, 2021
Clinical & Molecular DX
Black College Football Players More at Risk of Heart Conditions
SEP 28, 2021
Black College Football Players More at Risk of Heart Conditions
College football players may have an elevated risk of developing a heart condition where the left side of the heart beco ...
SEP 26, 2021
Genetics & Genomics
A Better Gene Therapy Delivery System for Treating Muscle Diseases
SEP 26, 2021
A Better Gene Therapy Delivery System for Treating Muscle Diseases
Muscle diseases that have a genetic basis can cause muscles to waste away, and may lead to a premature death. There aren ...
OCT 03, 2021
Microbiology
Using a New Approach to Assess Aging & the Microbiome
OCT 03, 2021
Using a New Approach to Assess Aging & the Microbiome
Metagenomic tools enable scientists to easily sequence all of the DNA in any sample, like soil, or feces. The results ca ...
OCT 07, 2021
Health & Medicine
A School-based Approach to Combatting Adolescent Obesity
OCT 07, 2021
A School-based Approach to Combatting Adolescent Obesity
It should come as no surprise that obesity is a significant public health concern associated with astronomical economic ...
OCT 13, 2021
Chemistry & Physics
The Nobel Prize in Chemistry
OCT 13, 2021
The Nobel Prize in Chemistry
It's Nobel Prize season, and the third to be awarded was in the field of Chemistry. The winners were two men working on ...
OCT 18, 2021
Health & Medicine
Emerging Research on Delta 8 THC
OCT 18, 2021
Emerging Research on Delta 8 THC
Delta-8-tetrahydrocannabinol is a cannabinoid derived from the hemp plant. It is one of the more prominent compounds, bu ...
Loading Comments...